摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-[(4,4'-dimethoxytrityl)oxymethyl]-2-methylpropan-3-ol-yl levulinate | 141719-97-3

中文名称
——
中文别名
——
英文名称
2-[(4,4'-dimethoxytrityl)oxymethyl]-2-methylpropan-3-ol-yl levulinate
英文别名
[2-[[Bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-hydroxy-2-methylpropyl] 4-oxopentanoate
2-[(4,4'-dimethoxytrityl)oxymethyl]-2-methylpropan-3-ol-yl levulinate化学式
CAS
141719-97-3
化学式
C31H36O7
mdl
——
分子量
520.623
InChiKey
LKFFKJKPZFTEIK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    658.1±55.0 °C(Predicted)
  • 密度:
    1.155±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    38
  • 可旋转键数:
    15
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    91.3
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-[(4,4'-dimethoxytrityl)oxymethyl]-2-methylpropan-3-ol-yl levulinate2-氰乙基N,N-二异丙基氯亚磷酰胺N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 1.5h, 以85%的产率得到2-[(4,4’-dimethoxytrityl)oxymethyl]-2-methylpropan-3-ol-yl levulinate (2-cyanoethyl-N,N-diisopropyl) phoshoramidite
    参考文献:
    名称:
    Modified Galacto‐ or Fuco‐Clusters Exploiting the Siderophore Pathway to Inhibit the LecA‐ or LecB‐Associated Virulence ofPseudomonas aeruginosa
    摘要:
    AbstractGalacto‐ and fuco‐clusters conjugated with one to three catechol or hydroxamate motifs were synthesised to target LecA and LecB lectins of Pseudomonas aeruginosa (PA) localised in the outer membrane and inside the bacterium. The resulting glycocluster–pseudosiderophore conjugates were evaluated as Trojan horses to cross the outer membrane of PA by iron transport. The data suggest that glycoclusters with catechol moieties are able to hijack the iron transport, whereas those with hydroxamates showed strong nonspecific interactions. Mono‐ and tricatechol galactoclusters (G1C and G3C) were evaluated as inhibitors of infection by PA in comparison with the free galactocluster (G0). All of them exhibited an inhibitory effect between 46 to 75 % at 100 μM, with a higher potency than G0. This result shows that LecA localised in the outer membrane of PA is involved in the infection mechanism.
    DOI:
    10.1002/cbic.202000490
  • 作为产物:
    参考文献:
    名称:
    化合物的制备方法
    摘要:
    本发明公开了一种化合物的制备方法,所述化合物具有如式I所示的结构,其通过化合物II与化合物III在酸/唑类配合物的作用下制备得到中间产物IV的溶液;中间产物IV溶液中加入化合物V,在酸/唑类配合物的作用下制备得到中间产物VI溶液;向中间产物VI的溶液中缓慢加入过氧化丁酮溶液,制得中间产物VII溶液;向中间产物VII的溶液中缓慢加入乙酸肼溶液,制得化合物VIII;化合物VIII在酸/唑类配合物作用下与化合物III反应制得化合物I。
    公开号:
    CN106866748B
点击查看最新优质反应信息

文献信息

  • BASELESS NUCLEOTIDE ANALOGUES AND USES THEREOF
    申请人:Clinical Micro Sensors, Inc.
    公开号:EP2220102B1
    公开(公告)日:2014-04-16
  • US7820391B2
    申请人:——
    公开号:US7820391B2
    公开(公告)日:2010-10-26
  • [EN] BASELESS NUCLEOTIDE ANALOGUES AND USES THEREOF<br/>[FR] ANALOGUES DE NUCLÉOTIDE SANS BASE ET LEURS UTILISATIONS
    申请人:OSMETECH MOLECULAR DIAGNOSTICS
    公开号:WO2009061941A2
    公开(公告)日:2009-05-14
    Baseless nucleotide analogs are provided. Said analogs are used in the detection of target nucleic acids. The analogs have formula (I) wherein X is a backbone spacer; S is a solubility moiety; t is 0 or 1; V is a redox active moiety; L1 and L2 are linkers; n = 0 or 1; m = 0 or 1; wherein n + m is at least 1; P1 and P2 are independently selected from the group consisting of hydrogen, phosphoramidite, a protecting group, and a nucleoside containing group, wherein at least one of P1 and P2 is said protecting group or said nucleoside containing group; and q is greater than or equal to 1.
  • 化合物的制备方法
    申请人:厦门云凡医药科技有限公司
    公开号:CN106866748B
    公开(公告)日:2018-05-15
    本发明公开了一种化合物的制备方法,所述化合物具有如式I所示的结构,其通过化合物II与化合物III在酸/唑类配合物的作用下制备得到中间产物IV的溶液;中间产物IV溶液中加入化合物V,在酸/唑类配合物的作用下制备得到中间产物VI溶液;向中间产物VI的溶液中缓慢加入过氧化丁酮溶液,制得中间产物VII溶液;向中间产物VII的溶液中缓慢加入乙酸肼溶液,制得化合物VIII;化合物VIII在酸/唑类配合物作用下与化合物III反应制得化合物I。
  • Modified Galacto‐ or Fuco‐Clusters Exploiting the Siderophore Pathway to Inhibit the LecA‐ or LecB‐Associated Virulence of<i>Pseudomonas aeruginosa</i>
    作者:Mimouna Madaoui、Olivier Vidal、Albert Meyer、Mathieu Noël、Jean‐Marie Lacroix、Jean‐Jacques Vasseur、Alberto Marra、François Morvan
    DOI:10.1002/cbic.202000490
    日期:2020.12
    AbstractGalacto‐ and fuco‐clusters conjugated with one to three catechol or hydroxamate motifs were synthesised to target LecA and LecB lectins of Pseudomonas aeruginosa (PA) localised in the outer membrane and inside the bacterium. The resulting glycocluster–pseudosiderophore conjugates were evaluated as Trojan horses to cross the outer membrane of PA by iron transport. The data suggest that glycoclusters with catechol moieties are able to hijack the iron transport, whereas those with hydroxamates showed strong nonspecific interactions. Mono‐ and tricatechol galactoclusters (G1C and G3C) were evaluated as inhibitors of infection by PA in comparison with the free galactocluster (G0). All of them exhibited an inhibitory effect between 46 to 75 % at 100 μM, with a higher potency than G0. This result shows that LecA localised in the outer membrane of PA is involved in the infection mechanism.
查看更多

同类化合物

(3-三苯基甲氨基甲基)吡啶 非马沙坦杂质1 隐色甲紫-d6 隐色孔雀绿-d6 隐色孔雀绿 隐色乙基结晶紫 降钙素杂质10 酸性黄117 酸性蓝119 酚酞啉 酚酞二硫酸钾水合物 萘,1-甲氧基-3-甲基 苯酚,4-(1,1-二苯基丙基)- 苯甲醇,4-溴-a-(4-溴苯基)-a-苯基- 苯甲酸,4-(羟基二苯甲基)-,甲基酯 苯甲基N-[(2(三苯代甲基四唑-5-基-1,1联苯基-4-基]-甲基-2-氨基-3-甲基丁酸酯 苯基双-(对二乙氨基苯)甲烷 苯基二甲苯基甲烷 苯基二[2-甲基-4-(二乙基氨基)苯基]甲烷 苯基{二[4-(三氟甲基)苯基]}甲醇 苯基-二(2-羟基-5-氯苯基)甲烷 苄基2,3,4-三-O-苄基-6-O-三苯甲基-BETA-D-吡喃葡萄糖苷 苄基 5-氨基-5-脱氧-2,3-O-异亚丙基-6-O-三苯甲基呋喃己糖苷 苄基 2-乙酰氨基-2-脱氧-6-O-三苯基-甲基-alpha-D-吡喃葡萄糖苷 苄基 2,3-O-异亚丙基-6-三苯甲基-alpha-D-甘露呋喃糖 膦酸,1,2-乙二基二(磷羧基甲基)亚氨基-3,1-丙二基次氮基<三价氮基>二(亚甲基)四-,盐钠 脱氢奥美沙坦-2三苯甲基奥美沙坦脂 美托咪定杂质28 绿茶提取物茶多酚陕西龙孚 结晶紫 磷,三(4-甲氧苯基)甲基-,碘化 碱性蓝 硫代硫酸氢 S-[2-[(3,3,3-三苯基丙基)氨基]乙基]酯 盐酸三苯甲基肼 白孔雀石绿-d5 甲酮,(反-4-氨基-4-甲基环己基)-4-吗啉基- 甲基三苯基甲基醚 甲基6-O-(三苯基甲基)-ALPHA-D-吡喃甘露糖苷三苯甲酸酯 甲基3,4-O-异亚丙基-2-O-甲基-6-O-三苯甲基吡喃己糖苷 甲基2-甲基-N-{[4-(三氟甲基)苯基]氨基甲酰}丙氨酸酸酯 甲基2,3,4-三-O-苯甲酰基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-苄基-6-O-三苯甲基-ALPHA-D-吡喃葡萄糖苷 甲基2,3,4-三-O-(苯基甲基)-6-O-(三苯基甲基)-ALPHA-D-吡喃半乳糖苷 甲基-6-O-三苯基甲基-alpha-D-吡喃葡萄糖苷 甲基(1-trityl-1H-imidazol-4-yl)乙酸酯 甲基 2,3,4-三-O-苄基-6-O-三苯基甲基-ALPHA-D-吡喃甘露糖苷 环丙胺,1-(1-甲基-1-丙烯-1-基)- 溶剂紫9 溴化N,N,N-三乙基-2-(三苯代甲基氧代)乙铵 海涛林